v3.23.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash $ 343,291 $ 132,487
Accounts receivable, net 12,535 34,767
Inventory, net 109,143 158,053
Prepaid expenses and other current assets 285,860 287,063
TOTAL CURRENT ASSETS 750,829 612,370
Property and equipment, net 26,410 27,296
Intangible assets, net 3,162,413 2,994,000
Long term deposits 23,416 23,065
Operating lease right-of-use assets - net 126,526 142,801
Goodwill 467,409 467,409
TOTAL ASSETS 4,557,003 4,266,941
CURRENT LIABILITIES:    
Accounts payable and accrued expenses 3,444,987 3,396,543
Notes payable 289,949 446,246
Convertible debentures, net of discount 739,315 482,885
Operating lease liabilities - current 108,376 119,065
Deferred revenues 75,907 39,170
Factoring liability 78,247 214,249
Derivative liability 4,519,536 2,717,633
TOTAL CURRENT LIABILITIES 9,256,317 7,415,791
Operating lease liabilities – non-current 13,836 23,068
TOTAL LIABILITIES 9,270,153 7,438,859
COMMITMENTS AND CONTINGENCIES (Note 11)
STOCKHOLDERS' DEFICIT    
Common stock - $0.001 par value; 200,000,000 shares authorized; 61,136,808 and 53,442,147 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 61,137 53,442
Additional paid in capital 20,092,577 19,391,400
Accumulated other comprehensive loss (260,890) (247,760)
Accumulated deficit (23,867,971) (21,631,241)
Stemtech Corporation stockholders’ deficit (3,975,147) (2,434,159)
Non-controlling interest in subsidiaries (738,003) (737,759)
TOTAL STOCKHOLDERS DEFICIT (4,713,150) (3,171,918)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 4,557,003 $ 4,266,941